Page 24 - Terminology-Clinical-Research
P. 24

use in humans, or as a treatment for a particular condition.  Field: Locus on a data collection instrument (usually a
                                                               CRF) for recording or displaying a data element.
        Experimental group: The group of subjects exposed to the
        new, researched treatment.  This group is often compared to  File Transfer Protocol (FTP): A standard protocol for
        a ‘control group’, the subjects who are not exposed to that   exchanging files between computers on the Internet.
        treatment.
                                                               Final report: A written description of a trial/study of any
        Experimental/investigational drug: A drug that has been   therapeutic, prophylactic, or diagnostic agent conducted
        authorized for use in a clinical trial but has not been granted  in human subjects, in which the clinical and statistical
        marketing approval as a treatment for a particular use.  description, presentations, and analyses are fully integrated
                                                               into a single report.
        Exploratory IND study: A clinical study that is conducted
        early in Phase 1; involves very limited human exposure   Finding: A meaningful interpretation of data or
        and has no therapeutic or diagnostic intent (e.g., screening   observations resulting from planned evaluations. Compare
        studies, microdose studies).                           to conclusion, hypothesis.

        Exploratory study: Phase 1 or 2 study during which     First human administration: See First-in-human study.
        the actions of a therapeutic intervention are assessed and
        measured. Note: Procedures in exploratory studies may   First received date: The First Received date is the date on
        appropriately be altered to expand the scope or method of   which summary clinical study protocol information was
        investigation. Compare to confirmatory study.          first submitted to the ClinicalTrials.gov registry. There is
                                                               typically a delay of a few days between the First Received
        Extraction transformation load (ETL): A class of       date and when the study information is available on
        software applications for data extraction, transformation,   ClinicalTrials.gov.
        and loading that are used to implement data interfaces
        between disparate database systems, often to populate data   First subject in (FSI, FPI): The date and time the first
        warehouses.                                            subject is enrolled and randomized into a study. The subject
                                                               will have met the inclusion/exclusion criteria to participate
        Extractive medicinal product: A medicinal product      in the trial and will have signed an informed consent form.
        derived from human tissue such as blood or plasma.     Synonym: first patient in.
                                                               First subject screened: First subject who signs the
                                                               informed consent form and is screened for potential
                                 F                             enrollment and randomization into a study but has not yet
                                                               been determined to meet the inclusion/exclusion criteria for
                                                               the trial.

                                                               First subject treated: First subject who receives the test
        Factorial design: Describes a clinical study in which   article or placebo in a clinical investigation.
        groups of participants receive one of several combinations
        of interventions. Note: For example, a two-by-two factorial   First-in-human study: A clinical trial where a medical
        design involves four groups of participants. Each group   procedure or medicinal product, previously developed and
        receives one of the following pairs of interventions: 1) drug   assessed through laboratory model or animal testing, or
        A and drug B, 2) drug A and a placebo, 3) a placebo and   through mathematical modeling is tested on human subjects
        drug B, or 4) a placebo and a placebo. So during the trial,   for the first time.
        all possible combinations of the two drugs (A and B) and
        the placebos are given to different groups of participants.   First-in-man study: See First-in-humans study.
        One type of intervention model (design).               First-line/second-line: The ‘line’ of treatment describes
                                                               the order in which it is tried as a therapy for cancer. A first-
        FDA: Food and Drug Administration.
                                                               line treatment is the initial treatment used to target tumors.
        FDAAA 801: Section 801 of the Food and Drug            Second-line treatment is given when first-line therapy
        Administration Amendments Act of 2007 (U.S. Public Law   doesn’t work or stops working.
        110-85).
                                                               Food and Drug Administration (FDA): An agency within
                                                               the U.S. Department of Health and Human Services. FDA

         24                                          AlphaScienceLabs.com
   19   20   21   22   23   24   25   26   27   28   29